To set up a press or media interview with this expert contact:

Charles Margulis

Cell: 510-560-3657


Erica C. Jones is the executive director of the Center on Disability at PHI and has served as director of the Pacific ADA Center since 1991.

The Pacific ADA Center is one of 10 regional centers that provide information, referrals, training, consultation and technical assistance to businesses, state and local governments, and the disability community about their responsibilities and rights under the Americans with Disabilities Act. The Center on Disability houses several disability-related projects sponsored by the federal government (including the Centers for Disease Control and Prevention) as well as state, county and private entities.

Jones has evaluated projects and national model programs with the Rehabilitation Services Administration, the Department of Education, university systems and nonprofit agencies. As director of public affairs for the President's Committee on Employment of People with Disabilities, she conducted a national public affairs program working closely with government entities, the Administration, the U.S. Congress and the public. She serves on several boards of directors, advisory boards and disability-related committees.

Jones received her BA from the University of Pennsylvania and completed all coursework toward an MEd in rehabilitation counseling. She obtained her MPH from the University of Hawaii, graduating magna cum laude.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.


Find Employment

Begin your career at the Public Health Institute.

See Jobs


New PHI Study on Breakthrough Infection Shows Steep Vaccine Efficacy Decline Over Six Months

A PHI study in the journal Science analyzed COVID infection by vaccination status among 780,225 Veterans. Researchers found that protection against any COVID-19 infection declined for all vaccine types, with overall vaccine protection declining from 87.9% in February to 48.1% by October 2021.

See the press release

Continue to